Entity Central Index Key Cover [Abstract] Document Type Document Type Amendment Flag Amendment Flag Document Period End Date Document Period End Date Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Trading Symbol Trading Symbol Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address Address Line1 Entity Address, Address Line Two Entity Address Address Line2 Entity Address, City or Town Entity Address City Or Town Entity Address, State or Province Entity Address State Or Province Entity Address, Postal Zip Code Entity Address Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Document Transition Report Document Transition Report Document Quarterly Report Document Quarterly Report Entity Registrant Name Entity Registrant Name Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Entity Filer Category Entity Filer Category Entity Small Business Entity Small Business Entity Emerging Growth Company Entity Emerging Growth Company Entity Ex Transition Period Entity Ex Transition Period Entity Shell Company Entity Shell Company Entity Current Reporting Status Entity Current Reporting Status Entity Common Stock, Shares Outstanding Entity Common Stock Shares Outstanding Security Exchange Name Security Exchange Name Title of 12(b) Security Security12b Title Entity Interactive Data Current Entity Interactive Data Current Entity Incorporation, State or Country Code Entity Incorporation State Country Code Accrued clinical supply cost. Statement Of Financial Position [Abstract] Assets Assets [Abstract] Current assets: Assets Current [Abstract] Cash and cash equivalents Cash And Cash Equivalents At Carrying Value Marketable securities Marketable Securities Current Prepaid expenses and other current assets Prepaid Expense And Other Assets Current Total current assets Assets Current Property and equipment, net Property Plant And Equipment Net Operating lease right-of-use assets Operating Lease Right Of Use Asset Restricted cash Restricted Cash Noncurrent Other assets Other Assets Noncurrent Total Assets Assets Liabilities and stockholders’ equity Liabilities And Stockholders Equity [Abstract] Current liabilities: Liabilities Current [Abstract] Accounts payable Accounts Payable Current Accrued clinical supply costs Accrued Clinical Supply Cost Accrued liabilities Accrued Liabilities Current Deferred revenue, current portion Contract With Customer Liability Current Operating lease liabilities, current portion Operating Lease Liability Current Total current liabilities Liabilities Current Deferred revenue, long-term portion Contract With Customer Liability Noncurrent Operating lease liabilities, long-term portion Operating Lease Liability Noncurrent Other long-term liabilities Other Liabilities Noncurrent Total liabilities Liabilities Stockholders' equity: Stockholders Equity [Abstract] Common stock, $0.0001 par value; 200,000,000 shares authorized as of September 30, 2020 and December 31, 2019 Common Stock Value Additional paid-in capital Additional Paid In Capital Accumulated other comprehensive income Accumulated Other Comprehensive Income Loss Net Of Tax Accumulated deficit Retained Earnings Accumulated Deficit Total stockholders' equity Stockholders Equity Total liabilities and stockholders’ equity Liabilities And Stockholders Equity Common stock, par value Common Stock Par Or Stated Value Per Share Common stock, shares authorized Common Stock Shares Authorized Statement Of Income And Comprehensive Income [Abstract] Total revenue Revenue From Contract With Customer Excluding Assessed Tax Type of Revenue [Extensible List] Type Of Revenue Extensible List Operating expenses: Operating Expenses [Abstract] Research and development Research And Development Expense General and administrative General And Administrative Expense Total operating expenses Operating Expenses Loss from operations Operating Income Loss Other income, net Other Nonoperating Income Expense Net loss Net Income Loss Unrealized gain (loss) on marketable securities Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax Comprehensive loss Comprehensive Income Net Of Tax Net loss per share, basic and diluted Earnings Per Share Basic And Diluted Shares used in computing net loss per share, basic and diluted Weighted Average Number Of Share Outstanding Basic And Diluted Statement Of Stockholders Equity [Abstract] Statement [Table] Statement [Table] Accumulated Other Comprehensive Income (Loss) Statement Equity Components [Axis] Equity Component Equity Component [Domain] Common Stock Common Stock [Member] Additional Paid-In Capital Additional Paid In Capital [Member] Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Income [Member] Accumulated Deficit Retained Earnings [Member] Class of Stock Statement Class Of Stock [Axis] Class of Stock Class Of Stock [Domain] Convertible Preferred Stock Convertible Preferred Stock [Member] Statement [Line Items] Statement [Line Items] Beginning Balance Convertible preferred stock, beginning balance (in shares) Temporary Equity Shares Outstanding Convertible preferred stock, beginning balance Temporary Equity Carrying Amount Attributable To Parent Beginning balance (in shares) Common Stock Shares Outstanding Issuance of common stock upon initial public offering, net of issuance costs Stock Issued During Period Value New Issues Issuance of common stock upon initial public offering, net of issuance costs (in shares) Stock Issued During Period Shares New Issues Conversion of convertible preferred stock into common stock Stock Issued During Period Value Conversion Of Convertible Securities Conversion of convertible preferred stock into common stock (in shares) Stock Issued During Period Shares Conversion Of Convertible Securities Exercise of stock options Stock Issued During Period Value Stock Options Exercised Exercise of stock options (in shares) Stock Issued During Period Shares Stock Options Exercised Purchase of common stock under employee stock option Stock Issued During Period Value Employee Stock Purchase Plan Purchase of common stock under employee stock option (in shares) Stock Issued During Period Shares Employee Stock Purchase Plans Forfeiture of restricted commonstock Stock Issued During Period Value Restricted Stock Award Forfeitures Forfeiture of restricted common stock (in shares) Stock Issued During Period Shares Restricted Stock Award Forfeited Stock-based compensation Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value Accumulated Other Comprehensive Income Loss Net Of Tax Aoci Including Portion Attributable To Noncontrolling Interest Period Increase Decrease Unrealized gain (loss) on marketable securities Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent Net loss Ending Balance Convertible preferred stock, ending balance (in shares) Convertible preferred stock, ending balance Ending balance (in shares) Issuance cost of common stock. Issuance cost of common stock Issuance Costs Of Common Stock Amortization right of use asset. Increase Decrease in accrued liabilities and accrued clinical supply costs. Amount of increase (decrease) of deferred rent. Increase (decrease) in lease liabilities. Proceeds from (payments for) issuance of common stock as part of an initial public offering. Proceeds from issuance of common stock upon follow-on public offering, net of issuance costs. Statement Of Cash Flows [Abstract] Cash flows from operating activities: Net Cash Provided By Used In Operating Activities [Abstract] Net loss Profit Loss Adjustments to reconcile net loss to net cash used in operating activities: Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract] Depreciation and amortization Depreciation And Amortization Stock-based compensation Share Based Compensation Amortization of premiums and accretion of discounts on marketable securities Accretion Amortization Of Discounts And Premiums Investments Amortization of right-of-use assets Amortization Right Of Use Asset Impairment loss on right-of-use asset Operating Lease Impairment Loss Loss from disposal of property and equipment, net Gain Loss On Sale Of Property Plant Equipment Changes in operating assets and liabilities: Increase Decrease In Operating Capital [Abstract] Prepaid expenses and other current assets Increase Decrease In Prepaid Deferred Expense And Other Assets Other assets Increase Decrease In Other Operating Assets Accounts payable Increase Decrease In Accounts Payable Accrued liabilities and accrued clinical supply costs Increase Decrease In Accrued Liabilities And Accrued Clinical Supply Costs Deferred revenue Increase Decrease In Contract With Customer Liability Deferred rent Increase Decrease In Deferred Rent Lease liabilities Increase Decrease In Lease Liabilities Other long-term liabilities Increase Decrease In Other Noncurrent Liabilities Net cash used in operating activities Net Cash Provided By Used In Operating Activities Cash flows from investing activities: Net Cash Provided By Used In Investing Activities [Abstract] Purchase of property and equipment Payments To Acquire Property Plant And Equipment Purchase of marketable securities Payments To Acquire Marketable Securities Maturities of marketable securities Proceeds From Sale And Maturity Of Marketable Securities Net cash used in investing activities Net Cash Provided By Used In Investing Activities Cash flows from financing activities: Net Cash Provided By Used In Financing Activities [Abstract] Proceeds from issuance of common stock upon initial public offering, net of issuance costs Proceeds From Payments For Issuance Initial Public Offering Proceeds from issuance of common stock upon follow-on public offering, net of issuance costs Proceeds From Issuance Of Common Stock Upon Follow On Public Offering Net Of Issuance Costs Proceeds from the exercise of options to purchase common stock Proceeds From Stock Options Exercised Purchase of common stock under employee stock purchase plan Proceeds From Stock Plans Net cash provided by financing activities Net Cash Provided By Used In Financing Activities Net increase (decrease) in cash, cash equivalents, and restricted cash Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Cash, cash equivalents, and restricted cash at beginning of period Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Cash, cash equivalents, and restricted cash at end of period Non-cash investing and financing activities: Cash Flow Noncash Investing And Financing Activities Disclosure [Abstract] Property and equipment purchases included in accounts payable and accrued liabilities Capital Expenditures Incurred But Not Yet Paid Tenant improvements paid by landlord Payments For Tenant Improvements Organization Consolidation And Presentation Of Financial Statements [Abstract] The Company and Liquidity Organization Consolidation And Presentation Of Financial Statements Disclosure [Text Block] Accounting Policies [Abstract] Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Fair Value Disclosures [Abstract] Fair Value Measurements Fair Value Disclosures [Text Block] Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] Stock-Based Compensation Disclosure Of Compensation Related Costs Share Based Payments [Text Block] Related Party Transactions [Abstract] Related Party Transactions Related Party Transactions Disclosure [Text Block] Earnings Per Share [Abstract] Net Loss Per Share Earnings Per Share [Text Block] Subsequent Events [Abstract] Subsequent Events Subsequent Events [Text Block] Basis of Presentation Basis Of Accounting Policy Policy [Text Block] Use of Estimates Use Of Estimates Concentration of Credit Risk Concentration Risk Credit Risk Cash, Cash Equivalents, and Restricted Cash Cash And Cash Equivalents Restricted Cash And Cash Equivalents Policy Fair Value of Financial Instruments Fair Value Of Financial Instruments Policy Revenue Recognition Revenue From Contract With Customer Policy [Text Block] Comprehensive Loss Comprehensive Income Policy Policy [Text Block] New Accounting Pronouncements New Accounting Pronouncements Policy Policy [Text Block] Schedule of Reconciliation of Cash, Cash Equivalents, and Restricted Cash Schedule Of Restricted Cash And Cash Equivalents [Text Block] Summary of Financial Assets Measured at Fair Value on a Recurring Basis Fair Value Assets Measured On Recurring Basis [Text Block] Summary of Recognized Stock-Based Compensation Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Text Block] Summary of Restricted Common Stock Schedule Of Nonvested Restricted Stock Units Activity Table [Text Block] Summary of Options to Purchase Common Stock Schedule Of Share Based Compensation Stock Options Activity Table [Text Block] Schedule of Dilutive Shares Excluded from Calculation of Diluted Net Loss Per Share Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Text Block] Organization consolidation and presentation of financial statements disclosure line items. Organization consolidation and presentation of financial statements disclosure table. Organization Consolidation And Presentation Of Financial Statements Disclosure [Table] Organization Consolidation And Presentation Of Financial Statements Disclosure [Table] Sale of Stock Subsidiary Sale Of Stock [Axis] Sale of Stock Sale Of Stock Name Of Transaction [Domain] Initial Public Offering I P O [Member] Over-Allotment Option Over Allotment Option [Member] Follow On Public Offering [Member] Follow-on-offering Follow On Public Offering [Member] Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items] Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items] Public offerings Share price Shares Issued Price Per Share Proceeds from issuance of common stock, net of underwriting discounts and commissions and offering expenses Proceeds From Issuance Initial Public Offering Convertible preferred stock, shares outstanding Conversion of convertible preferred stock to common stock Convertible Preferred Stock Shares Issued Upon Conversion Summary of significant accounting policies. Summary of significant accounting policies. Summary Of Significant Accounting Policies [Table] Summary Of Significant Accounting Policies [Table] Cash and Cash Equivalents Cash And Cash Equivalents [Axis] Cash and Cash Equivalents Restricted Cash And Cash Equivalents Cash And Cash Equivalents [Member] Money Market Funds Money Market Funds [Member] Counterparty Name Counterparty Name [Axis] Counterparty Name Repurchase Agreement Counterparty Name [Domain] AbbVie biotechnology, limited. AbbVie Biotechnology Limited Abb Vie Biotechnology Limited [Member] Statistical Measurement Range [Axis] Statistical Measurement Range [Member] Maximum Maximum [Member] Minimum Minimum [Member] Innovent Biologics. Innovent Innovent Biologics [Member] Debt Security Category Information By Category Of Debt Security [Axis] Other than Temporary Impairment, Credit Losses Recognized in Earnings, Categories of Investments Other Than Temporary Impairment Credit Losses Recognized In Earnings Categories Of Investments [Domain] Available-for-Sale Investments Availableforsale Securities [Member] Accounting Standards Update Adjustments For New Accounting Pronouncements [Axis] Accounting Standards Update Type Of Adoption [Member] ASU 2016-13 Accounting Standards Update201613 [Member] Summary Of Significant Accounting Policies [Line Items] Summary Of Significant Accounting Policies [Line Items] Unrealized gains or loss on money market funds Unrealized Gain Loss On Investments Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents [Abstract] Total cash, cash equivalents, and restricted cash Collaborative arrangement, upfront payments. Collaborative arrangement, milestone payments on option rights exercised per program. Collaborative arrangement, additional milestone payments receivable per program. Upfront payments Collaborative Arrangement Upfront Payments Upfront payment received Proceeds From Collaborators Exclusive option rights exercised for each program Collaborative Arrangement Milestone Payments On Option Rights Exercised Per Program Additional milestone payments per program related to initiation of certain clinical studies and regulatory approval Collaborative Arrangement Additional Milestone Payments Receivable Per Program Development milestone. Sales milestone. Increase In Expected Cost Percentage. Increase in expected cost percentage Increase In Expected Cost Percentage Reduced revenue Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price Collaboration revenue Contract With Customer Liability Revenue Recognized Deferred revenue Contract With Customer Liability Development milestone Development Milestone Sales milestone Sales Milestone Accrued interest receivable Accrued Investment Income Receivable Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table] Fair Value, Measurements, Recurring Fair Value By Measurement Frequency [Axis] Measurement Frequency Fair Value Measurement Frequency [Domain] Fair Value, Measurements, Recurring Fair Value Measurements Recurring [Member] Asset Class Fair Value By Asset Class [Axis] Asset Class Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation By Asset Class [Domain] U.S Government Treasury Securities U S Treasury Securities [Member] Commercial Paper Commercial Paper [Member] Corporate Bonds Corporate Bond Securities [Member] Fair Value Hierarchy and NAV Fair Value By Fair Value Hierarchy Level [Axis] Fair Value Hierarchy and NAV Fair Value Measurements Fair Value Hierarchy [Domain] Level 1 Fair Value Inputs Level1 [Member] Level 2 Fair Value Inputs Level2 [Member] Cash equivalents and marketable securities. Cash Equivalents and Marketable Securities Cash Equivalents And Marketable Securities [Member] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] Cash equivalents and marketable securities, Amortized Cost Available For Sale Debt Securities Amortized Cost Basis Cash equivalents and marketable securities, Unrealized Gains Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax Cash equivalents and marketable securities, Unrealized Losses Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax Cash equivalents and marketable securities, Fair Market Value Assets Fair Value Disclosure Available For Sale Securities Debt Maturities Within One Through Two Year Fair Value. Remaining contractual maturities of investments were less than one year Available For Sale Securities Debt Maturities Within One Year Fair Value Remaining contractual maturities of investments were less than one year through two years Available For Sale Securities Debt Maturities Within One Through Two Year Fair Value Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Income Statement Location Income Statement Location [Axis] Income Statement Location Income Statement Location [Domain] Research and Development Research And Development Expense [Member] General and Administrative General And Administrative Expense [Member] Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Total stock-based compensation Allocated Share Based Compensation Expense Award Type Award Type [Axis] Award Type Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain] Restricted Common Stock Restricted Stock [Member] Number of Shares Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Roll Forward Number of Shares, Unvested, beginning balance Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number Number of Shares, Vested Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Number of Shares, Unvested, ending balance Weighted-average grant-date fair value Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value Roll Forward Weighted Average Grant Date Fair Value per Share, Unvested, beginning balance Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value Weighted Average Grant Date Fair Value per Share, Vested Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value Weighted Average Grant Date Fair Value per Share, Unvested, ending balance Plan Name Plan Name [Axis] Plan Name Plan Name [Domain] Two thousand nineteen equity incentive plan. 2019 Equity Incentive Plan Two Thousand Nineteen Equity Incentive Plan [Member] Two thousand nineteen employee stock purchase plan. 2019 Employee Stock Purchase Plan Two Thousand Nineteen Employee Stock Purchase Plan [Member] Unrecognized stock-based compensation Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Expected weighted average period Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 Common stock reserved for issuance Common Stock Capital Shares Reserved For Future Issuance Common stock, shares available for issuance Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Number of Options, Outstanding, beginning balance Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number Number of Options, Granted Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross Number of Options, Exercised Number of Options, Forfeited Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period Number of Options, Outstanding, ending balance Number of Options, Exercisable Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number Number of Options, Vested and expected to vest Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number Weighted average exercise price, Outstanding, beginning balance Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Weighted average exercise price, Granted Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price Weighted average exercise price, Exercised Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price Weighted average exercise price, Forfeited Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price Weighted average exercise price, Outstanding, ending balance Weighted average exercise price, Exercisable Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price Weighted average exercise price, Vested and expected to vest Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price Weighted Average Remaining Contractual Term, Outstanding (in years) Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 Weighted Average Remaining Contractual Term, Exercisable (In years) Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 Weighted Average Remaining Contractual Term, Vested and expected to vest (In years) Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 Aggregate Intrinsic Value, Outstanding Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value Aggregate Intrinsic Value, Exercisable Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 Aggregate Intrinsic Value, Vested or expected to vest Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value Unrecognized stock-based compensation Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options Subsequent offering period. Purchase price of common stock, percentage Share Based Compensation Arrangement By Share Based Payment Award Discount From Market Price Purchase Date Subsequent offering period Subsequent Offering Period Future milestone payments owed. Schedule Of Related Party Transactions By Related Party [Table] Schedule Of Related Party Transactions By Related Party [Table] Related Party Related Party Transactions By Related Party [Axis] Related Party Related Party [Domain] Adimab Agreement Two Thousand Fourteen Adimab Agreement Two Thousand Fourteen Adimab Agreement [Member] Adimab Adimab [Member] Title of Individual Title Of Individual [Axis] Title of Individual Title Of Individual With Relationship To Entity [Domain] Director Director [Member] Related Party Transaction [Line Items] Related Party Transaction [Line Items] Related party transaction expenses Related Party Transaction Expenses From Transactions With Related Party Accrued liabilities due to related parties Due To Related Parties Current Future milestone payments owed Future Milestone Payments Owed Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Antidilutive Securities Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis] Antidilutive Securities, Name Antidilutive Securities Name [Domain] Options to Purchase Common Stock Employee Stock Option [Member] Shares Committed Under ESPP Employee Stock [Member] Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] Anti-dilutive shares Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount Date which lease or group of leases is commenced, in CCYY-MM-DD format. Subsequent Event [Table] Subsequent Event [Table] Subsequent Event Type Subsequent Event Type [Axis] Subsequent Event Type Subsequent Event Type [Domain] Subsequent Event [Member] Subsequent Event [Member] Subsequent Event [Line Items] Subsequent Event [Line Items] Lease, description Lessee Operating Lease Description Area of property Area Of Real Estate Property Lease commencement, date Lease Commencement Date Lease, term Lessee Operating Lease Term Of Contract Fixed rent payments Lessee Operating Lease Liability Payments Due Lease, option to extend Lessee Operating Lease Existence Of Option To Extend Extend for an additional lease term Lessor Operating Lease Renewal Term